Most cited papers from Jubilee Clinical Research

Jubilee Clinical Research

What are the most cited papers from Jubilee Clinical Research?

The most cited paper from Jubilee Clinical Research is "Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH" (Rohit Seth Loomba et al., 2020), with 290 citations. Next come "Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial" (220) and "Problems with Rayleigh Damping in Base-Isolated Buildings" (120).

Published FieldAccessCitations

Showing 9 of 9 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH Rohit Seth Loomba et al. · Hepatology	10 Nov 2020	290
2	Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial Naim Alkhouri, Robert Herring, Heidi Kabler et al. · Journal of Hepatology Open access	16 Apr 2022	220
3	Problems with Rayleigh Damping in Base-Isolated Buildings Keri L. Ryan, José Polanco · Journal of Structural Engineering	17 Oct 2008	120
4	Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial William D. O’Riordan, Carrie Cardenas, Elliot Shin et al. · The Lancet Infectious Diseases	29 Aug 2019	98
5	The effect of dead-on-arrival and emergency department death classification on risk-adjusted performance in the American College of Surgeons Trauma Quality Improvement Program James Forrest Calland, Avery B. Nathens, Jeffrey S. Young et al. · The Journal of Trauma: Injury, Infection, and Critical Care	Nov 2012	44
6	Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial Rohit Seth Loomba et al. · Journal of Hepatology	Aug 2020	9
7	When Treatment Meets Natural History: Understanding Early Dermatitis‐Related Adverse Events in Systemic Atopic Dermatitis Trials Diego Ruiz Dasilva, Alondra Soto‐Gonzalez, Haya Alkiswani et al. · JEADV Clinical Practice Open access	24 Aug 2026	0
8	Introduction to atopic dermatitis Taraneh Matin, Christopher M. Logas, Brad P. Glick et al. · Dermatological Reviews	2 Dec 2021	0
9	Emerging therapies in pediatric atopic dermatitis patients Alexandra Bowles, Christopher M. Logas, Brad P. Glick et al. · Dermatological Reviews	21 Jan 2022	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.